➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Afimoxifene

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Afimoxifene?

Afimoxifene is an investigational drug.

There have been 5 clinical trials for Afimoxifene. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.

The most common disease conditions in clinical trials are Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast, and Carcinoma in Situ. The leading clinical trial sponsors are National Cancer Institute (NCI), Northwestern University, and BHR Pharma, LLC.

Recent Clinical Trials for Afimoxifene
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One BreastNational Cancer Institute (NCI)Phase 2
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One BreastNorthwestern UniversityPhase 2
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense BreastBHR Pharma, LLCPhase 2

See all Afimoxifene clinical trials

Clinical Trial Summary for Afimoxifene

Top disease conditions for Afimoxifene
Top clinical trial sponsors for Afimoxifene

See all Afimoxifene clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.